Dr Rajendrasinh Jahubhai Rathod, MD | |
148 W River St Ste 8, Providence, RI 02904-2615 | |
(401) 606-3000 | |
(401) 331-8110 |
Full Name | Dr Rajendrasinh Jahubhai Rathod |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 22 Years |
Location | 148 W River St Ste 8, Providence, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417159229 | NPI | - | NPPES |
1417159229 | Medicaid | RI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD15449 (Rhode Island) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Miriam Hospital | Providence, RI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lifespan Physician Group Inc | 2567455082 | 631 |
Lifespan Physician Group Inc | 2567455082 | 631 |
News Archive
Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.
A new study from the University of Cincinnati has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA).
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
Come ride with the thrill of fresh air in your face. This ride supports prostate cancer awareness, one of the leading killers of men in the state of Georgia. According to the American Cancer Society, Georgia ranks 6th in highest estimated deaths caused by prostate cancer; this is a serious concern for the state and for Radiotherapy Centers of Georgia, a center of excellence in treatment for prostate cancer.
› Verified 4 days ago
Entity Name | Affinity Physicians Llc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184944662 PECOS PAC ID: 0244413391 Enrollment ID: O20110326000053 |
News Archive
Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.
A new study from the University of Cincinnati has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA).
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
Come ride with the thrill of fresh air in your face. This ride supports prostate cancer awareness, one of the leading killers of men in the state of Georgia. According to the American Cancer Society, Georgia ranks 6th in highest estimated deaths caused by prostate cancer; this is a serious concern for the state and for Radiotherapy Centers of Georgia, a center of excellence in treatment for prostate cancer.
› Verified 4 days ago
Entity Name | Lifespan Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.
A new study from the University of Cincinnati has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA).
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
Come ride with the thrill of fresh air in your face. This ride supports prostate cancer awareness, one of the leading killers of men in the state of Georgia. According to the American Cancer Society, Georgia ranks 6th in highest estimated deaths caused by prostate cancer; this is a serious concern for the state and for Radiotherapy Centers of Georgia, a center of excellence in treatment for prostate cancer.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rajendrasinh Jahubhai Rathod, MD 117 Ellenfield St Ste 101, Providence, RI 02905-4513 Ph: (401) 444-6779 | Dr Rajendrasinh Jahubhai Rathod, MD 148 W River St Ste 8, Providence, RI 02904-2615 Ph: (401) 606-3000 |
News Archive
Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.
A new study from the University of Cincinnati has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA).
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
Come ride with the thrill of fresh air in your face. This ride supports prostate cancer awareness, one of the leading killers of men in the state of Georgia. According to the American Cancer Society, Georgia ranks 6th in highest estimated deaths caused by prostate cancer; this is a serious concern for the state and for Radiotherapy Centers of Georgia, a center of excellence in treatment for prostate cancer.
› Verified 4 days ago
Donald Ramos, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 695 Eddy St, Providence, RI 02903 Phone: 401-272-1550 Fax: 401-421-8792 | |
Brittany S Hampton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1100 | |
Dr. Jane R. Sharp, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 297 Promenade St, Providence, RI 02908 Phone: 401-490-6464 | |
Dr. Katharine D Wenstrom, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 101 Dudley Street, 3rd Floor, Women & Infants Hospital Of Rhode Island/mfm Division, Providence, RI 02905 Phone: 401-274-1122 Fax: 401-453-7622 | |
Rebecca Crichton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 | |
Heather A Smith, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 | |
Meena Theva, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1122 |